1. Home
  2. MEDP vs HSIC Comparison

MEDP vs HSIC Comparison

Compare MEDP & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEDP
  • HSIC
  • Stock Information
  • Founded
  • MEDP 1992
  • HSIC 1932
  • Country
  • MEDP United States
  • HSIC United States
  • Employees
  • MEDP N/A
  • HSIC N/A
  • Industry
  • MEDP Biotechnology: Commercial Physical & Biological Resarch
  • HSIC Medical Specialities
  • Sector
  • MEDP Health Care
  • HSIC Health Care
  • Exchange
  • MEDP Nasdaq
  • HSIC Nasdaq
  • Market Cap
  • MEDP 8.5B
  • HSIC 9.0B
  • IPO Year
  • MEDP 2016
  • HSIC 1995
  • Fundamental
  • Price
  • MEDP $311.87
  • HSIC $69.10
  • Analyst Decision
  • MEDP Hold
  • HSIC Buy
  • Analyst Count
  • MEDP 11
  • HSIC 10
  • Target Price
  • MEDP $338.90
  • HSIC $78.70
  • AVG Volume (30 Days)
  • MEDP 387.7K
  • HSIC 1.7M
  • Earning Date
  • MEDP 07-21-2025
  • HSIC 08-05-2025
  • Dividend Yield
  • MEDP N/A
  • HSIC N/A
  • EPS Growth
  • MEDP 33.36
  • HSIC 8.11
  • EPS
  • MEDP 13.09
  • HSIC 3.21
  • Revenue
  • MEDP $2,156,580,000.00
  • HSIC $12,669,000,000.00
  • Revenue This Year
  • MEDP $5.69
  • HSIC $4.28
  • Revenue Next Year
  • MEDP $3.36
  • HSIC $3.57
  • P/E Ratio
  • MEDP $23.83
  • HSIC $21.57
  • Revenue Growth
  • MEDP 9.87
  • HSIC 1.75
  • 52 Week Low
  • MEDP $250.05
  • HSIC $60.56
  • 52 Week High
  • MEDP $441.27
  • HSIC $82.49
  • Technical
  • Relative Strength Index (RSI)
  • MEDP 48.47
  • HSIC 35.09
  • Support Level
  • MEDP $309.97
  • HSIC $68.71
  • Resistance Level
  • MEDP $334.33
  • HSIC $73.23
  • Average True Range (ATR)
  • MEDP 8.95
  • HSIC 1.63
  • MACD
  • MEDP -1.21
  • HSIC -0.66
  • Stochastic Oscillator
  • MEDP 13.38
  • HSIC 5.53

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Share on Social Networks: